Leading The Way: Adult ADHD Guidelines
The First Guidelines for the Clinical Diagnosis and Treatment of Adult ADHD in the United States
With no clinical practice guidelines, healthcare providers are not taught how to diagnose and treat ADHD in adults. This has created a significant gap in mental healthcare across the country.
The recent surge in adults seeking care for ADHD, coupled with a steady increase in ADHD medication prescriptions, has underscored the pressing need for consistent diagnostic and treatment guidelines for adults in the United States. Untreated ADHD has negative consequences across all aspects of society, and establishment of adult guidelines will ensure greater and more consistent access to care.
CHADD has partnered with the American Professional Society for ADHD and Related Disorders (APSARD) to develop and distribute guidelines in 2025. APSARD is leading the charge in developing the guidelines for review based on a firm foundation of research established by the Adult ADHD Quality Measures Initiative, which for the past five years has developed and tested metrics for the quality care of adults with ADHD.
CHADD, in partnership with the Adult ADHD Coalition, (consisting of representatives from the American Psychiatric Association, the American Association of Nurse Practitioners, the American Academy of Neurology, the American Psychological Association, the National Alliance on Mental Illness, and led by Dr. Peter Jensen, Founder and Board Chair of The REACH Institute), is developing and distributing the guidelines' educational toolkit. An accessible and interactive educational toolkit will reach all health care providers and therapists on the front lines of diagnosis and treatment -- not just those who specialize in ADHD.
ADULT ADHD GUIDELINES DEVELOPMENT
The Importance of Adult ADHD Guidelines
Dr. Peter Jensen, founder and Board Chair of the REACH Institute, is the director of a coalition of national organizations that are developing adult ADHD diagnosis and treatment guidelines for use in the United States, a joint effort of CHADD and APSARD.
For more information on the development of adult guidelines, read The Quest for Clinical Practice Guidelines for ADHD in Adults.
PROJECT UPDATES
Featuring Max Wiznitzer, MD, Co-chair of CHADD’s Professional Advisory Board Download PDF Learn more about ADHD before the lunch and learn: About ADHD – Overview The Science of ADHD Diagnosing ADHD Treatment of ADHD Frequently Asked Questions Have questions? Email the public policy co-chairs at PublicPolicyLiaison@CHADD.org. The CHADD Public Policy Lunch and Learn is…
In 2022, CHADD received funds from a generous donor to sponsor and support the development of national guidelines in the U.S. for the diagnosis and treatment of adult ADHD. This milestone has been achieved due to the sustained efforts of our Public Policy Committee and builds on the committee’s published recommendations emerging from a national…
CHADD and Russell A. Barkley, Ph.D., Partner Announce New Findings Lanham, Md. (Jan. 8, 2019)— The message is clear. Treatment for attention-deficit/hyperactivity disorder (ADHD), along with the related health risks it poses, has the possibility of adding an average of nine to 13 years to the lifespan of children and adults diagnosed with ADHD. This…
- « Previous
- 1
- 2